论文部分内容阅读
目的:评估全视网膜光凝术(PRP)对糖尿病视网膜病变(PDR)患者在视觉相关生活质量及日常视觉功能的影响。方法:研究纳入30例(男13例,女17例)接受全视网膜光凝术治疗糖尿病视网膜病变患者。国家眼科研究所发布的视觉功能量表(VFQ-25)用来评估全视网膜光凝术治疗前后视觉相关生活质量及日常视觉功能。患者在接受全视网膜光凝术治疗前和治疗后6mo分别填写VFQ-25量表,比较视觉相关生活质量及日常视觉功能差异。运用配对t检验对治疗前后VFQ-25评分对比。结果:全视网膜光凝术治疗前平均VFQ-25综合评分为74.79±15.7,术后平均综合评分为74.08±19.1。术前与术后的平均VFQ-25综合评分无统计学意义(P=0.875)。结论:全视网膜光凝术(PRP)对糖尿病视网膜病变(PDR)患者在视觉相关生活质量及日常视觉功能无不利影响。
Objectives: To evaluate the effect of panretinal photocoagulation (PRP) on visual-related quality of life and daily visual function in patients with diabetic retinopathy (PDR). Methods: Thirty patients (13 males and 17 females) underwent panretinal photocoagulation for the treatment of diabetic retinopathy. The Visual Function Scale (VFQ-25) issued by the National Eye Institute was used to assess the visual quality of life and visual function before and after panretinal photocoagulation. Patients underwent total retinal photocoagulation and 6 months after treatment were filled VFQ-25 scale, compared with visual quality of life and daily visual differences. Comparisons of VFQ-25 scores before and after treatment using paired t-test. Results: The average VFQ-25 comprehensive score before panretinal photocoagulation was 74.79 ± 15.7 and the average postoperative composite score was 74.08 ± 19.1. The mean preoperative and postoperative VFQ-25 composite scores were not statistically significant (P = 0.875). CONCLUSIONS: Retinal photocoagulation (PRP) has no adverse effect on visual quality of life and daily visual function in patients with diabetic retinopathy (PDR).